Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC;   Radiation: Stereotactic Body Radiation Therapy (SBRT) Sponsors:   Weill Medical College of Cornell University;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials